Article
Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.
Oncology reports - 1 Oct 2011
Zekri Abdel-Rahman N, Bahnassy Abeer A, Alam El-Din Hanaa M, Morsy Heba M, Shaarawy Sabry, Moharram Nagia Z, Daoud Sayed S
Abstract excerpt
The global rising incidence of hepatocellular carcinoma (HCC), which parallels the increase of hepatitis C virus (HCV) prevalence, has sparked a renewed interest in discovering additional HCC serum markers. In this study, we investigated the clinical use of serum E-cadherin, ICAM, MMP-2, VEGF, OPN and β-catenin as potential diagnostic makers for HCV/genotype 4-associated HCC. Twenty cases of healthy subjects, 11...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
